Chronic Administration of Visfatin Ameliorated Diabetic Nephropathy in Type 2 Diabetic Mice.

Young Sun Kang,Mi Hwa Lee,Hye Kyoung Song,Jung Eun Kim,Jung Yeon Ghee,Jin Joo Cha,Ji Eun Lee,Hyunwook Kim,Jee Young Han,Dae Ryong Cha

Chronic Administration of Visfatin Ameliorated Diabetic Nephropathy in Type 2 Diabetic Mice.

2016

Young Sun Kang
Mi Hwa Lee
Hye Kyoung Song
Jung Eun Kim
Jung Yeon Ghee
Jin Joo Cha
Ji Eun Lee
Hyunwook Kim
Jee Young Han
Dae Ryong Cha

Background/Aims: Visfatin is a known adipokine which may improve insulin resistance in obesity and have an anti-diabetic effect via the insulin receptor. We studi

Keywords:

Insulin resistance
Endocrinology
Obesity
Adipokine
Insulin receptor
Internal medicine
Diabetic nephropathy
Diabetes mellitus
Medicine
Hypoglycemia
Inbred strain

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations